Abstract:Biomimetic nanoparticles aim to effectively emulate the behavior of either cells or exosomes. Leukocyte-based biomimetic nanoparticles, for instance, incorporate cell membrane proteins to transfer the natural tropism of leukocytes to the final delivery platform. However, tuning the protein integration can affect the in vivo behavior of these nanoparticles and alter their efficacy. Here we show that, while increasing the protein:lipid ratio to a maximum of 1:20 (w/w) maintained the nanoparticle's structural properties, increasing protein content resulted in improved targeting of inflamed endothelium in two different animal models. Our combined use of a microfluidic, bottom-up approach and tuning of a key synthesis parameter enabled the synthesis of reproducible, enhanced biomimetic nanoparticles that have the potential to improve the treatment of inflammatory-based conditions through targeted nanodelivery.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c05792?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c05792</a>.Effect of protein buffer on NP size (Figure S1). Native protein:lipid ratio (Figure S2). NP biomimetic markers, original WB membranes, and quantification (Figure S3). CD11b orientation studies revealed equal distribution of these cytoplasmic and exoplasmic parts (Figure S4). 21-day NP storage stability studies (Figure S5). Gating strategy for flow cytometry analysis of NP uptake (Figure S6). Non-inflamed and LPS-inflamed endothelial cells (Figure S7). In vitro association and uptake of biomimetic NP by non-inflamed murine endothelial cells (Figure S8). Percentage of positive cells in singlet gate of inflamed treated cells (Figure S9). Ex vivo imaging of left and right ears for biomimetic NP targeting in a LLI model (Figure S10). TNBC tumor luminescence quantification (Figure S11). In vivo biomimetic NP liver accumulation in TNBC model (Figure S12). Ex vivo imaging of TNBC tumors for NP accumulation after 24 h (Figure S13). Intravital microscopy for NP accumulation in inflamed vasculature of TNBC mice (Figure S14). Biomimetic NP accumulation in heart, lungs, and spleen in LLI model after 8 h (Figure S15). Biomimetic NP accumulation in liver, kidneys, and blood in LLI model after 8 h (Figure S16). Biomimetic NP accumulation in heart, lungs, spleen, liver, kidneys, and blood of TNBC tumor-bearing mice after 24 h (Figure S17). Image analysis of collagen fibers workflow (Figure S18) (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05792/suppl_file/nn0c05792_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Combination of Physicochemical Tropism and Affinity Moiety Targeting of Lipid Nanoparticles Enhances Organ Targeting

Tuning Targeted Liposome Avidity to Cells via Lipid Phase Separation

Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions

Microfluidic Self-Assembly of a Combinatorial Library of Single- and Dual-Ligand Liposomes for in Vitro and in Vivo Tumor Targeting

Lipid Nanoparticle (LNP) Chemistry Can Endow Unique in Vivo RNA Delivery Fates Within the Liver That Alter Therapeutic Outcomes in a Cancer Model

Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery

On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles

Tuning Lipid Nanoparticles for RNA Delivery to Extrahepatic Organs

Strategies for Organ-Targeted mRNA Delivery by Lipid Nanoparticles.

Advancements in Lipid Nanoparticle Technologies for Precision Targeting in Therapeutic Delivery

The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles

Lipid Nanoparticles With Fine‐Tuned Composition Show Enhanced Colon Targeting as a Platform for mRNA Therapeutics

Nonspecific Organelle-Targeting Strategy with Core-Shell Nanoparticles of Varied Lipid Components/Ratios.

"Hook&loop" Multivalent Interactions Based on Disk-Shaped Nanoparticles Strengthen Active Targeting.

Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles

Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation

Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium

'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective

Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery

Design and investigation of targeting agent orientation and density on nanoparticles for enhancing cellular uptake efficiency

Pulmonary Delivery of Dual-Targeted Nanoparticles Improves Tumor Accumulation and Cancer Cell Targeting by Restricting Macrophage Interception in Orthotopic Lung Tumors.